Estrogen-Releasing Elastic Sheet for Intrauterine Adhesion Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for intrauterine adhesions, such as hysteroscopic adhesiolysis, are inadequate in preventing re-adhesion and restoring endometrial function, particularly in cases of severe adhesions, and existing drug delivery methods like oral and transdermal administration are inefficient and cause side effects.
Innovation Solution
An elastic sheet made of silicone rubber with embedded or coated estrogen and optional additional drugs is designed for intrauterine use, providing sustained release to stimulate endometrial basal layer regeneration and prevent adhesions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If hysteroscopic adhesiolysis is performed to separate adhesions, then the uterine cavity shape is restored, but re-adhesion occurs and endometrial function is not restored
Solution Approach 1:
The elastic sheet is implanted into the uterine cavity before the endometrial basal layer fully regenerates, performing preliminary protection and drug delivery. The sheet releases estrogen and other drugs that stimulate basal layer proliferation and prevent adhesion formation during the critical regeneration period, addressing both prevention and function restoration simultaneously
Solution Approach 2:
The elastic sheet is composed of multiple materials with different functions: silicone rubber provides structural support and elasticity, while embedded drugs (estrogen, progesterone, growth factors) provide biological activity. This composite structure allows the sheet to both mechanically separate adhesion sites and pharmacologically promote endometrial regeneration
2Quantity of substance
If oral or transdermal estrogen administration is used to stimulate endometrial proliferation, then endometrial thickness increases, but side effects occur and drug delivery efficiency is low
Solution Approach 1:
The elastic sheet delivers estrogen locally directly to the endometrial basal layer through embedded drug reservoirs or surface coating. This localized delivery ensures high drug concentration at the target site for effective endometrial proliferation while minimizing systemic circulation and associated side effects such as thromboembolism and breast cancer risk
Solution Approach 2:
The elastic sheet acts as an intermediary carrier between the estrogen drug and the endometrial basal layer. The silicone rubber matrix or coating serves as a controlled-release system, mediating the delivery of estrogen directly to the basal layer cells that need stimulation for proliferation, bypassing the liver's first-pass metabolism and reducing systemic exposure
3Duration of action of moving object
If the elastic sheet is made thicker to provide longer drug release, then drug delivery duration increases, but insertion difficulty increases
Solution Approach 1:
The elastic sheet is designed with dynamic properties that allow it to change shape during insertion and remain in place afterward. The silicone rubber material provides elasticity and flexibility, enabling the sheet to be compressed into a thin profile for easy cervical insertion, then expand to its full thickness within the uterine cavity to provide sustained drug release over time
Solution Approach 2:
The elastic sheet can be folded or rolled into a compact form that nests within a delivery device or catheter for insertion. Once inside the uterine cavity, the sheet unfolds or expands to its full dimensions, providing the necessary thickness for drug reservoirs or coating while maintaining ease of insertion through the narrow cervical canal
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The elastic sheet effectively activates the endometrial basal layer, promoting functional layer re-proliferation, preventing adhesions, and restoring normal endometrial structure without significant side effects, as demonstrated by in vivo studies.
Implementation Method 1
the drug is encased inside the silicone rubber in the manner of a storage zone, or uniformly dispersed inside the silicone rubber, or carried by an outer surface of the silicone rubber as a coating
Data Source
AI summary
An elastic sheet for re-activating an endometrial basal layer in a uterine cavity comprises a silicone rubber and a drug, wherein the drug is encased inside the silicone rubber in the manner of a drug storage zone, or uniformly dispersed inside the silicone rubber, or carried by an outer surface of the silicone rubber as a coating, and the drug comprises an estrogen. A method for forming the elastic sheet with a drug in a matrix-type elastic sheet; or as a sustained release coating is provided. The estrogen is loaded on the silicone rubber, and thus the endometrial basal layer is continuously activated through drug stimulation, allowing for the endometrial basal layer to re-proliferate the functional layers, thereby restoring the normal endometrial structure and completely preventing adhesions.